Global Non-alcoholic Steatohepatitis Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Non-alcoholic Steatohepatitis market size was valued at USD 2605.3 million in 2023 and is forecast to a readjusted size of USD 9170.5 million by 2030 with a CAGR of 19.7% during review period.
Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver.
NASH is a progressive liver disease characterized by fat accumulation in the liver, inflammation, and liver cell damage, typically occurring in individuals who do not consume excessive alcohol. Several factors are driving the growth of the NASH market. Firstly, the rising prevalence of obesity and metabolic disorders, such as diabetes and dyslipidemia, is contributing to the increasing incidence of NASH. Unhealthy lifestyles, sedentary habits, and poor dietary choices are leading to a higher risk of developing NASH, creating a substantial patient population in need of diagnosis and treatment. Secondly, the improved understanding and awareness of NASH among healthcare professionals and the general population have resulted in increased diagnosis rates. As the medical community recognizes the long-term complications and progression of NASH, there is a greater emphasis on identifying patients with NASH and implementing appropriate management strategies.
The Global Info Research report includes an overview of the development of the Non-alcoholic Steatohepatitis industry chain, the market status of Oral (Solid, Liquid), Parenteral (Solid, Liquid), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-alcoholic Steatohepatitis.
Regionally, the report analyzes the Non-alcoholic Steatohepatitis markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-alcoholic Steatohepatitis market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Non-alcoholic Steatohepatitis market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-alcoholic Steatohepatitis industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Solid, Liquid).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-alcoholic Steatohepatitis market.
Regional Analysis: The report involves examining the Non-alcoholic Steatohepatitis market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-alcoholic Steatohepatitis market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Non-alcoholic Steatohepatitis:
Company Analysis: Report covers individual Non-alcoholic Steatohepatitis players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-alcoholic Steatohepatitis This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oral, Parenteral).
Technology Analysis: Report covers specific technologies relevant to Non-alcoholic Steatohepatitis. It assesses the current state, advancements, and potential future developments in Non-alcoholic Steatohepatitis areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-alcoholic Steatohepatitis market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Non-alcoholic Steatohepatitis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Non-alcoholic Steatohepatitis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-alcoholic Steatohepatitis, with revenue, gross margin and global market share of Non-alcoholic Steatohepatitis from 2019 to 2024.
Chapter 3, the Non-alcoholic Steatohepatitis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Non-alcoholic Steatohepatitis market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-alcoholic Steatohepatitis.
Chapter 13, to describe Non-alcoholic Steatohepatitis research findings and conclusion.
Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver.
NASH is a progressive liver disease characterized by fat accumulation in the liver, inflammation, and liver cell damage, typically occurring in individuals who do not consume excessive alcohol. Several factors are driving the growth of the NASH market. Firstly, the rising prevalence of obesity and metabolic disorders, such as diabetes and dyslipidemia, is contributing to the increasing incidence of NASH. Unhealthy lifestyles, sedentary habits, and poor dietary choices are leading to a higher risk of developing NASH, creating a substantial patient population in need of diagnosis and treatment. Secondly, the improved understanding and awareness of NASH among healthcare professionals and the general population have resulted in increased diagnosis rates. As the medical community recognizes the long-term complications and progression of NASH, there is a greater emphasis on identifying patients with NASH and implementing appropriate management strategies.
The Global Info Research report includes an overview of the development of the Non-alcoholic Steatohepatitis industry chain, the market status of Oral (Solid, Liquid), Parenteral (Solid, Liquid), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-alcoholic Steatohepatitis.
Regionally, the report analyzes the Non-alcoholic Steatohepatitis markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-alcoholic Steatohepatitis market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Non-alcoholic Steatohepatitis market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-alcoholic Steatohepatitis industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Solid, Liquid).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-alcoholic Steatohepatitis market.
Regional Analysis: The report involves examining the Non-alcoholic Steatohepatitis market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-alcoholic Steatohepatitis market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Non-alcoholic Steatohepatitis:
Company Analysis: Report covers individual Non-alcoholic Steatohepatitis players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-alcoholic Steatohepatitis This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oral, Parenteral).
Technology Analysis: Report covers specific technologies relevant to Non-alcoholic Steatohepatitis. It assesses the current state, advancements, and potential future developments in Non-alcoholic Steatohepatitis areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-alcoholic Steatohepatitis market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Non-alcoholic Steatohepatitis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Solid
- Liquid
- Oral
- Parenteral
- AstraZeneca
- Pfizer
- GSK
- Novo Nordisk
- Roche
- AbbVie
- Galectin Therapeutics
- Galmed Pharmaceuticals
- Gilead
- Intercept pharma
- Non-alcoholic Steatohepatitis
- Takeda
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Non-alcoholic Steatohepatitis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-alcoholic Steatohepatitis, with revenue, gross margin and global market share of Non-alcoholic Steatohepatitis from 2019 to 2024.
Chapter 3, the Non-alcoholic Steatohepatitis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Non-alcoholic Steatohepatitis market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-alcoholic Steatohepatitis.
Chapter 13, to describe Non-alcoholic Steatohepatitis research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Non-alcoholic Steatohepatitis
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-alcoholic Steatohepatitis by Type
1.3.1 Overview: Global Non-alcoholic Steatohepatitis Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Type in 2023
1.3.3 Solid
1.3.4 Liquid
1.4 Global Non-alcoholic Steatohepatitis Market by Application
1.4.1 Overview: Global Non-alcoholic Steatohepatitis Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oral
1.4.3 Parenteral
1.5 Global Non-alcoholic Steatohepatitis Market Size & Forecast
1.6 Global Non-alcoholic Steatohepatitis Market Size and Forecast by Region
1.6.1 Global Non-alcoholic Steatohepatitis Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Non-alcoholic Steatohepatitis Market Size by Region, (2019-2030)
1.6.3 North America Non-alcoholic Steatohepatitis Market Size and Prospect (2019-2030)
1.6.4 Europe Non-alcoholic Steatohepatitis Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Non-alcoholic Steatohepatitis Market Size and Prospect (2019-2030)
1.6.6 South America Non-alcoholic Steatohepatitis Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Non-alcoholic Steatohepatitis Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Non-alcoholic Steatohepatitis Product and Solutions
2.1.4 AstraZeneca Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Non-alcoholic Steatohepatitis Product and Solutions
2.2.4 Pfizer Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Non-alcoholic Steatohepatitis Product and Solutions
2.3.4 GSK Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GSK Recent Developments and Future Plans
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Non-alcoholic Steatohepatitis Product and Solutions
2.4.4 Novo Nordisk Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novo Nordisk Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Non-alcoholic Steatohepatitis Product and Solutions
2.5.4 Roche Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Roche Recent Developments and Future Plans
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Non-alcoholic Steatohepatitis Product and Solutions
2.6.4 AbbVie Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AbbVie Recent Developments and Future Plans
2.7 Galectin Therapeutics
2.7.1 Galectin Therapeutics Details
2.7.2 Galectin Therapeutics Major Business
2.7.3 Galectin Therapeutics Non-alcoholic Steatohepatitis Product and Solutions
2.7.4 Galectin Therapeutics Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Galectin Therapeutics Recent Developments and Future Plans
2.8 Galmed Pharmaceuticals
2.8.1 Galmed Pharmaceuticals Details
2.8.2 Galmed Pharmaceuticals Major Business
2.8.3 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product and Solutions
2.8.4 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Galmed Pharmaceuticals Recent Developments and Future Plans
2.9 Gilead
2.9.1 Gilead Details
2.9.2 Gilead Major Business
2.9.3 Gilead Non-alcoholic Steatohepatitis Product and Solutions
2.9.4 Gilead Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Gilead Recent Developments and Future Plans
2.10 Intercept pharma
2.10.1 Intercept pharma Details
2.10.2 Intercept pharma Major Business
2.10.3 Intercept pharma Non-alcoholic Steatohepatitis Product and Solutions
2.10.4 Intercept pharma Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Intercept pharma Recent Developments and Future Plans
2.11 Non-alcoholic Steatohepatitis
2.11.1 Non-alcoholic Steatohepatitis Details
2.11.2 Non-alcoholic Steatohepatitis Major Business
2.11.3 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product and Solutions
2.11.4 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Non-alcoholic Steatohepatitis Recent Developments and Future Plans
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business
2.12.3 Takeda Non-alcoholic Steatohepatitis Product and Solutions
2.12.4 Takeda Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Takeda Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-alcoholic Steatohepatitis Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Non-alcoholic Steatohepatitis by Company Revenue
3.2.2 Top 3 Non-alcoholic Steatohepatitis Players Market Share in 2023
3.2.3 Top 6 Non-alcoholic Steatohepatitis Players Market Share in 2023
3.3 Non-alcoholic Steatohepatitis Market: Overall Company Footprint Analysis
3.3.1 Non-alcoholic Steatohepatitis Market: Region Footprint
3.3.2 Non-alcoholic Steatohepatitis Market: Company Product Type Footprint
3.3.3 Non-alcoholic Steatohepatitis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-alcoholic Steatohepatitis Consumption Value and Market Share by Type (2019-2024)
4.2 Global Non-alcoholic Steatohepatitis Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2019-2024)
5.2 Global Non-alcoholic Steatohepatitis Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2030)
6.2 North America Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2030)
6.3 North America Non-alcoholic Steatohepatitis Market Size by Country
6.3.1 North America Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2030)
6.3.2 United States Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
6.3.3 Canada Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
6.3.4 Mexico Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2030)
7.2 Europe Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2030)
7.3 Europe Non-alcoholic Steatohepatitis Market Size by Country
7.3.1 Europe Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2030)
7.3.2 Germany Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
7.3.3 France Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
7.3.5 Russia Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
7.3.6 Italy Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Region
8.3.1 Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Region (2019-2030)
8.3.2 China Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
8.3.3 Japan Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
8.3.4 South Korea Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
8.3.5 India Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
8.3.7 Australia Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2030)
9.2 South America Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2030)
9.3 South America Non-alcoholic Steatohepatitis Market Size by Country
9.3.1 South America Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2030)
9.3.2 Brazil Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
9.3.3 Argentina Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Non-alcoholic Steatohepatitis Market Size by Country
10.3.1 Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2030)
10.3.2 Turkey Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
10.3.4 UAE Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Non-alcoholic Steatohepatitis Market Drivers
11.2 Non-alcoholic Steatohepatitis Market Restraints
11.3 Non-alcoholic Steatohepatitis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-alcoholic Steatohepatitis Industry Chain
12.2 Non-alcoholic Steatohepatitis Upstream Analysis
12.3 Non-alcoholic Steatohepatitis Midstream Analysis
12.4 Non-alcoholic Steatohepatitis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Non-alcoholic Steatohepatitis
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-alcoholic Steatohepatitis by Type
1.3.1 Overview: Global Non-alcoholic Steatohepatitis Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Type in 2023
1.3.3 Solid
1.3.4 Liquid
1.4 Global Non-alcoholic Steatohepatitis Market by Application
1.4.1 Overview: Global Non-alcoholic Steatohepatitis Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oral
1.4.3 Parenteral
1.5 Global Non-alcoholic Steatohepatitis Market Size & Forecast
1.6 Global Non-alcoholic Steatohepatitis Market Size and Forecast by Region
1.6.1 Global Non-alcoholic Steatohepatitis Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Non-alcoholic Steatohepatitis Market Size by Region, (2019-2030)
1.6.3 North America Non-alcoholic Steatohepatitis Market Size and Prospect (2019-2030)
1.6.4 Europe Non-alcoholic Steatohepatitis Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Non-alcoholic Steatohepatitis Market Size and Prospect (2019-2030)
1.6.6 South America Non-alcoholic Steatohepatitis Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Non-alcoholic Steatohepatitis Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Non-alcoholic Steatohepatitis Product and Solutions
2.1.4 AstraZeneca Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Non-alcoholic Steatohepatitis Product and Solutions
2.2.4 Pfizer Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Non-alcoholic Steatohepatitis Product and Solutions
2.3.4 GSK Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GSK Recent Developments and Future Plans
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Non-alcoholic Steatohepatitis Product and Solutions
2.4.4 Novo Nordisk Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novo Nordisk Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Non-alcoholic Steatohepatitis Product and Solutions
2.5.4 Roche Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Roche Recent Developments and Future Plans
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Non-alcoholic Steatohepatitis Product and Solutions
2.6.4 AbbVie Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AbbVie Recent Developments and Future Plans
2.7 Galectin Therapeutics
2.7.1 Galectin Therapeutics Details
2.7.2 Galectin Therapeutics Major Business
2.7.3 Galectin Therapeutics Non-alcoholic Steatohepatitis Product and Solutions
2.7.4 Galectin Therapeutics Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Galectin Therapeutics Recent Developments and Future Plans
2.8 Galmed Pharmaceuticals
2.8.1 Galmed Pharmaceuticals Details
2.8.2 Galmed Pharmaceuticals Major Business
2.8.3 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product and Solutions
2.8.4 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Galmed Pharmaceuticals Recent Developments and Future Plans
2.9 Gilead
2.9.1 Gilead Details
2.9.2 Gilead Major Business
2.9.3 Gilead Non-alcoholic Steatohepatitis Product and Solutions
2.9.4 Gilead Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Gilead Recent Developments and Future Plans
2.10 Intercept pharma
2.10.1 Intercept pharma Details
2.10.2 Intercept pharma Major Business
2.10.3 Intercept pharma Non-alcoholic Steatohepatitis Product and Solutions
2.10.4 Intercept pharma Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Intercept pharma Recent Developments and Future Plans
2.11 Non-alcoholic Steatohepatitis
2.11.1 Non-alcoholic Steatohepatitis Details
2.11.2 Non-alcoholic Steatohepatitis Major Business
2.11.3 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product and Solutions
2.11.4 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Non-alcoholic Steatohepatitis Recent Developments and Future Plans
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business
2.12.3 Takeda Non-alcoholic Steatohepatitis Product and Solutions
2.12.4 Takeda Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Takeda Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-alcoholic Steatohepatitis Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Non-alcoholic Steatohepatitis by Company Revenue
3.2.2 Top 3 Non-alcoholic Steatohepatitis Players Market Share in 2023
3.2.3 Top 6 Non-alcoholic Steatohepatitis Players Market Share in 2023
3.3 Non-alcoholic Steatohepatitis Market: Overall Company Footprint Analysis
3.3.1 Non-alcoholic Steatohepatitis Market: Region Footprint
3.3.2 Non-alcoholic Steatohepatitis Market: Company Product Type Footprint
3.3.3 Non-alcoholic Steatohepatitis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-alcoholic Steatohepatitis Consumption Value and Market Share by Type (2019-2024)
4.2 Global Non-alcoholic Steatohepatitis Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2019-2024)
5.2 Global Non-alcoholic Steatohepatitis Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2030)
6.2 North America Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2030)
6.3 North America Non-alcoholic Steatohepatitis Market Size by Country
6.3.1 North America Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2030)
6.3.2 United States Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
6.3.3 Canada Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
6.3.4 Mexico Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2030)
7.2 Europe Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2030)
7.3 Europe Non-alcoholic Steatohepatitis Market Size by Country
7.3.1 Europe Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2030)
7.3.2 Germany Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
7.3.3 France Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
7.3.5 Russia Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
7.3.6 Italy Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Region
8.3.1 Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Region (2019-2030)
8.3.2 China Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
8.3.3 Japan Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
8.3.4 South Korea Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
8.3.5 India Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
8.3.7 Australia Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2030)
9.2 South America Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2030)
9.3 South America Non-alcoholic Steatohepatitis Market Size by Country
9.3.1 South America Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2030)
9.3.2 Brazil Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
9.3.3 Argentina Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Non-alcoholic Steatohepatitis Market Size by Country
10.3.1 Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2030)
10.3.2 Turkey Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
10.3.4 UAE Non-alcoholic Steatohepatitis Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Non-alcoholic Steatohepatitis Market Drivers
11.2 Non-alcoholic Steatohepatitis Market Restraints
11.3 Non-alcoholic Steatohepatitis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-alcoholic Steatohepatitis Industry Chain
12.2 Non-alcoholic Steatohepatitis Upstream Analysis
12.3 Non-alcoholic Steatohepatitis Midstream Analysis
12.4 Non-alcoholic Steatohepatitis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-alcoholic Steatohepatitis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Non-alcoholic Steatohepatitis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Non-alcoholic Steatohepatitis Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Non-alcoholic Steatohepatitis Consumption Value by Region (2025-2030) & (USD Million)
Table 5. AstraZeneca Company Information, Head Office, and Major Competitors
Table 6. AstraZeneca Major Business
Table 7. AstraZeneca Non-alcoholic Steatohepatitis Product and Solutions
Table 8. AstraZeneca Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. AstraZeneca Recent Developments and Future Plans
Table 10. Pfizer Company Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Non-alcoholic Steatohepatitis Product and Solutions
Table 13. Pfizer Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Recent Developments and Future Plans
Table 15. GSK Company Information, Head Office, and Major Competitors
Table 16. GSK Major Business
Table 17. GSK Non-alcoholic Steatohepatitis Product and Solutions
Table 18. GSK Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GSK Recent Developments and Future Plans
Table 20. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 21. Novo Nordisk Major Business
Table 22. Novo Nordisk Non-alcoholic Steatohepatitis Product and Solutions
Table 23. Novo Nordisk Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novo Nordisk Recent Developments and Future Plans
Table 25. Roche Company Information, Head Office, and Major Competitors
Table 26. Roche Major Business
Table 27. Roche Non-alcoholic Steatohepatitis Product and Solutions
Table 28. Roche Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Roche Recent Developments and Future Plans
Table 30. AbbVie Company Information, Head Office, and Major Competitors
Table 31. AbbVie Major Business
Table 32. AbbVie Non-alcoholic Steatohepatitis Product and Solutions
Table 33. AbbVie Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. AbbVie Recent Developments and Future Plans
Table 35. Galectin Therapeutics Company Information, Head Office, and Major Competitors
Table 36. Galectin Therapeutics Major Business
Table 37. Galectin Therapeutics Non-alcoholic Steatohepatitis Product and Solutions
Table 38. Galectin Therapeutics Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Galectin Therapeutics Recent Developments and Future Plans
Table 40. Galmed Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 41. Galmed Pharmaceuticals Major Business
Table 42. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product and Solutions
Table 43. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Galmed Pharmaceuticals Recent Developments and Future Plans
Table 45. Gilead Company Information, Head Office, and Major Competitors
Table 46. Gilead Major Business
Table 47. Gilead Non-alcoholic Steatohepatitis Product and Solutions
Table 48. Gilead Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Gilead Recent Developments and Future Plans
Table 50. Intercept pharma Company Information, Head Office, and Major Competitors
Table 51. Intercept pharma Major Business
Table 52. Intercept pharma Non-alcoholic Steatohepatitis Product and Solutions
Table 53. Intercept pharma Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Intercept pharma Recent Developments and Future Plans
Table 55. Non-alcoholic Steatohepatitis Company Information, Head Office, and Major Competitors
Table 56. Non-alcoholic Steatohepatitis Major Business
Table 57. Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product and Solutions
Table 58. Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Non-alcoholic Steatohepatitis Recent Developments and Future Plans
Table 60. Takeda Company Information, Head Office, and Major Competitors
Table 61. Takeda Major Business
Table 62. Takeda Non-alcoholic Steatohepatitis Product and Solutions
Table 63. Takeda Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Takeda Recent Developments and Future Plans
Table 65. Global Non-alcoholic Steatohepatitis Revenue (USD Million) by Players (2019-2024)
Table 66. Global Non-alcoholic Steatohepatitis Revenue Share by Players (2019-2024)
Table 67. Breakdown of Non-alcoholic Steatohepatitis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Non-alcoholic Steatohepatitis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Non-alcoholic Steatohepatitis Players
Table 70. Non-alcoholic Steatohepatitis Market: Company Product Type Footprint
Table 71. Non-alcoholic Steatohepatitis Market: Company Product Application Footprint
Table 72. Non-alcoholic Steatohepatitis New Market Entrants and Barriers to Market Entry
Table 73. Non-alcoholic Steatohepatitis Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Non-alcoholic Steatohepatitis Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Non-alcoholic Steatohepatitis Consumption Value Share by Type (2019-2024)
Table 76. Global Non-alcoholic Steatohepatitis Consumption Value Forecast by Type (2025-2030)
Table 77. Global Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2024)
Table 78. Global Non-alcoholic Steatohepatitis Consumption Value Forecast by Application (2025-2030)
Table 79. North America Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Non-alcoholic Steatohepatitis Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America Non-alcoholic Steatohepatitis Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Non-alcoholic Steatohepatitis Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Non-alcoholic Steatohepatitis Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe Non-alcoholic Steatohepatitis Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Non-alcoholic Steatohepatitis Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Non-alcoholic Steatohepatitis Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America Non-alcoholic Steatohepatitis Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Non-alcoholic Steatohepatitis Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Non-alcoholic Steatohepatitis Raw Material
Table 110. Key Suppliers of Non-alcoholic Steatohepatitis Raw Materials
Table 1. Global Non-alcoholic Steatohepatitis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Non-alcoholic Steatohepatitis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Non-alcoholic Steatohepatitis Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Non-alcoholic Steatohepatitis Consumption Value by Region (2025-2030) & (USD Million)
Table 5. AstraZeneca Company Information, Head Office, and Major Competitors
Table 6. AstraZeneca Major Business
Table 7. AstraZeneca Non-alcoholic Steatohepatitis Product and Solutions
Table 8. AstraZeneca Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. AstraZeneca Recent Developments and Future Plans
Table 10. Pfizer Company Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Non-alcoholic Steatohepatitis Product and Solutions
Table 13. Pfizer Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Pfizer Recent Developments and Future Plans
Table 15. GSK Company Information, Head Office, and Major Competitors
Table 16. GSK Major Business
Table 17. GSK Non-alcoholic Steatohepatitis Product and Solutions
Table 18. GSK Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GSK Recent Developments and Future Plans
Table 20. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 21. Novo Nordisk Major Business
Table 22. Novo Nordisk Non-alcoholic Steatohepatitis Product and Solutions
Table 23. Novo Nordisk Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novo Nordisk Recent Developments and Future Plans
Table 25. Roche Company Information, Head Office, and Major Competitors
Table 26. Roche Major Business
Table 27. Roche Non-alcoholic Steatohepatitis Product and Solutions
Table 28. Roche Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Roche Recent Developments and Future Plans
Table 30. AbbVie Company Information, Head Office, and Major Competitors
Table 31. AbbVie Major Business
Table 32. AbbVie Non-alcoholic Steatohepatitis Product and Solutions
Table 33. AbbVie Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. AbbVie Recent Developments and Future Plans
Table 35. Galectin Therapeutics Company Information, Head Office, and Major Competitors
Table 36. Galectin Therapeutics Major Business
Table 37. Galectin Therapeutics Non-alcoholic Steatohepatitis Product and Solutions
Table 38. Galectin Therapeutics Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Galectin Therapeutics Recent Developments and Future Plans
Table 40. Galmed Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 41. Galmed Pharmaceuticals Major Business
Table 42. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product and Solutions
Table 43. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Galmed Pharmaceuticals Recent Developments and Future Plans
Table 45. Gilead Company Information, Head Office, and Major Competitors
Table 46. Gilead Major Business
Table 47. Gilead Non-alcoholic Steatohepatitis Product and Solutions
Table 48. Gilead Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Gilead Recent Developments and Future Plans
Table 50. Intercept pharma Company Information, Head Office, and Major Competitors
Table 51. Intercept pharma Major Business
Table 52. Intercept pharma Non-alcoholic Steatohepatitis Product and Solutions
Table 53. Intercept pharma Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Intercept pharma Recent Developments and Future Plans
Table 55. Non-alcoholic Steatohepatitis Company Information, Head Office, and Major Competitors
Table 56. Non-alcoholic Steatohepatitis Major Business
Table 57. Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product and Solutions
Table 58. Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Non-alcoholic Steatohepatitis Recent Developments and Future Plans
Table 60. Takeda Company Information, Head Office, and Major Competitors
Table 61. Takeda Major Business
Table 62. Takeda Non-alcoholic Steatohepatitis Product and Solutions
Table 63. Takeda Non-alcoholic Steatohepatitis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Takeda Recent Developments and Future Plans
Table 65. Global Non-alcoholic Steatohepatitis Revenue (USD Million) by Players (2019-2024)
Table 66. Global Non-alcoholic Steatohepatitis Revenue Share by Players (2019-2024)
Table 67. Breakdown of Non-alcoholic Steatohepatitis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Non-alcoholic Steatohepatitis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Non-alcoholic Steatohepatitis Players
Table 70. Non-alcoholic Steatohepatitis Market: Company Product Type Footprint
Table 71. Non-alcoholic Steatohepatitis Market: Company Product Application Footprint
Table 72. Non-alcoholic Steatohepatitis New Market Entrants and Barriers to Market Entry
Table 73. Non-alcoholic Steatohepatitis Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Non-alcoholic Steatohepatitis Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Non-alcoholic Steatohepatitis Consumption Value Share by Type (2019-2024)
Table 76. Global Non-alcoholic Steatohepatitis Consumption Value Forecast by Type (2025-2030)
Table 77. Global Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2024)
Table 78. Global Non-alcoholic Steatohepatitis Consumption Value Forecast by Application (2025-2030)
Table 79. North America Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Non-alcoholic Steatohepatitis Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America Non-alcoholic Steatohepatitis Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Non-alcoholic Steatohepatitis Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Non-alcoholic Steatohepatitis Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe Non-alcoholic Steatohepatitis Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Non-alcoholic Steatohepatitis Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Non-alcoholic Steatohepatitis Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America Non-alcoholic Steatohepatitis Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Non-alcoholic Steatohepatitis Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Non-alcoholic Steatohepatitis Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Non-alcoholic Steatohepatitis Raw Material
Table 110. Key Suppliers of Non-alcoholic Steatohepatitis Raw Materials
LIST OF FIGURES
Figure 1. Non-alcoholic Steatohepatitis Picture
Figure 2. Global Non-alcoholic Steatohepatitis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Type in 2023
Figure 4. Solid
Figure 5. Liquid
Figure 6. Global Non-alcoholic Steatohepatitis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Non-alcoholic Steatohepatitis Consumption Value Market Share by Application in 2023
Figure 8. Oral Picture
Figure 9. Parenteral Picture
Figure 10. Global Non-alcoholic Steatohepatitis Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Non-alcoholic Steatohepatitis Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Non-alcoholic Steatohepatitis Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Region in 2023
Figure 15. North America Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Non-alcoholic Steatohepatitis Revenue Share by Players in 2023
Figure 21. Non-alcoholic Steatohepatitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Non-alcoholic Steatohepatitis Market Share in 2023
Figure 23. Global Top 6 Players Non-alcoholic Steatohepatitis Market Share in 2023
Figure 24. Global Non-alcoholic Steatohepatitis Consumption Value Share by Type (2019-2024)
Figure 25. Global Non-alcoholic Steatohepatitis Market Share Forecast by Type (2025-2030)
Figure 26. Global Non-alcoholic Steatohepatitis Consumption Value Share by Application (2019-2024)
Figure 27. Global Non-alcoholic Steatohepatitis Market Share Forecast by Application (2025-2030)
Figure 28. North America Non-alcoholic Steatohepatitis Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Non-alcoholic Steatohepatitis Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Non-alcoholic Steatohepatitis Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Non-alcoholic Steatohepatitis Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 38. France Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value Market Share by Region (2019-2030)
Figure 45. China Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 48. India Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Non-alcoholic Steatohepatitis Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Non-alcoholic Steatohepatitis Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Non-alcoholic Steatohepatitis Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Non-alcoholic Steatohepatitis Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 62. Non-alcoholic Steatohepatitis Market Drivers
Figure 63. Non-alcoholic Steatohepatitis Market Restraints
Figure 64. Non-alcoholic Steatohepatitis Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Non-alcoholic Steatohepatitis in 2023
Figure 67. Manufacturing Process Analysis of Non-alcoholic Steatohepatitis
Figure 68. Non-alcoholic Steatohepatitis Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Non-alcoholic Steatohepatitis Picture
Figure 2. Global Non-alcoholic Steatohepatitis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Type in 2023
Figure 4. Solid
Figure 5. Liquid
Figure 6. Global Non-alcoholic Steatohepatitis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Non-alcoholic Steatohepatitis Consumption Value Market Share by Application in 2023
Figure 8. Oral Picture
Figure 9. Parenteral Picture
Figure 10. Global Non-alcoholic Steatohepatitis Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Non-alcoholic Steatohepatitis Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Non-alcoholic Steatohepatitis Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Non-alcoholic Steatohepatitis Consumption Value Market Share by Region in 2023
Figure 15. North America Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Non-alcoholic Steatohepatitis Revenue Share by Players in 2023
Figure 21. Non-alcoholic Steatohepatitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Non-alcoholic Steatohepatitis Market Share in 2023
Figure 23. Global Top 6 Players Non-alcoholic Steatohepatitis Market Share in 2023
Figure 24. Global Non-alcoholic Steatohepatitis Consumption Value Share by Type (2019-2024)
Figure 25. Global Non-alcoholic Steatohepatitis Market Share Forecast by Type (2025-2030)
Figure 26. Global Non-alcoholic Steatohepatitis Consumption Value Share by Application (2019-2024)
Figure 27. Global Non-alcoholic Steatohepatitis Market Share Forecast by Application (2025-2030)
Figure 28. North America Non-alcoholic Steatohepatitis Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2019-2030)
Figure 30. North America Non-alcoholic Steatohepatitis Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Non-alcoholic Steatohepatitis Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe Non-alcoholic Steatohepatitis Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 38. France Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific Non-alcoholic Steatohepatitis Consumption Value Market Share by Region (2019-2030)
Figure 45. China Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 48. India Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Non-alcoholic Steatohepatitis Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2019-2030)
Figure 53. South America Non-alcoholic Steatohepatitis Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Non-alcoholic Steatohepatitis Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Non-alcoholic Steatohepatitis Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa Non-alcoholic Steatohepatitis Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Non-alcoholic Steatohepatitis Consumption Value (2019-2030) & (USD Million)
Figure 62. Non-alcoholic Steatohepatitis Market Drivers
Figure 63. Non-alcoholic Steatohepatitis Market Restraints
Figure 64. Non-alcoholic Steatohepatitis Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Non-alcoholic Steatohepatitis in 2023
Figure 67. Manufacturing Process Analysis of Non-alcoholic Steatohepatitis
Figure 68. Non-alcoholic Steatohepatitis Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
